Found 19 matching trials
Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test N/A This study prospectively included 150 breast cancer patients (30 patients i...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Decision Impact Study of PreciseDx Breast N/A The investigator's developed a digital LDT to predict invasive breast cance...
Show More Location
Multiple Locations
Learn More & Join Trial
Validation of 70-gene MammaPrint Profile in Japanese Population N/A By using gene-expression profiling, Van't Veer and colleagues developed a 7...
Show More Location
Osaka Medical Center for Cancer and Cadiovascular Diseases
Learn More & Join Trial
The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy N/A Rationale:
Prediction of prognosis in patients with breast cancer is impor...
Show More Location
Whilhelmina ziekenhuis
Learn More & Join Trial
The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients N/A This study is experimental and will prospectively assess the proportion of ...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer NA The need/benefit of adjuvant chemotherapy could be negligible for a certain...
Show More Location
Multiple Locations
Learn More & Join Trial
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer PHASE3 This phase III trial compares the addition of an immunotherapy drug (durval...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I PHASE4 Genomics assays that measure specific gene expression patterns in a patient...
Show More Location
University of South Alabama, Mitchell Cancer Institute
Learn More & Join Trial
PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS N/A There is only limited data for premenopausal patients in general, as well a...
Show More Location
Klinikum-Mittelbaden GmbH, Studienzentrale/Brustzentrum
Learn More & Join Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles N/A The FLEX Registry will be implemented to operate as a large-scale, populati...
Show More Learn More & Join Trial